Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009. It is a high-tech enterprise that produces high-end APIs such as anti-viral, anti-tumor, hypoglycemic, and anti-allergic. The company's predecessor was established in the 1990s, with more than 20 years of experience in the production of anti-virus, diabetes and anti-tumor raw materials. Subsequently, the entire enterprise moved to Anqing City, Anhui Province, the registered capital of the company is 3.3 million USD. The registered address is No.21 Huancheng West Road, Daguan District, Anqing City, Anhui Province 246000 China. After many years of development, currently there are 35 R&D teams, quality department personnel and EHS management personnel, with a total number of more than 90, and 25 technical personnel with undergraduate degrees or above. The company has reached cooperation with East China Normal University, Anhui University, Zhejiang University of Technology, China Pharmaceutical University and Anqing University as an internship base for undergraduate and graduate students. The company has now completed the first phase of the project, obtained the pollution discharge permit, completed the occupational health prevention and control acceptance, and successfully obtained the "three-level safety production standardization" certificate and the drug production license. The company invest in the second phase of the project in 2022, built up two GMP raw material drug production workshops with a total area of 10,000 square meters; 8,000 square meters of research and development buildings and warehouses. The output value of the second phase is expected to reach 60 million USD.